Highlightll Pharma

Hangzhou, China · Founded 2017 · In IPO Registration

Developer of a drug development approach designed to create therapies for autoimmune and inflammatory diseases affecting systemic and central nervous system conditions. Highlightll Pharma is based in Hangzhou, China and was founded in 2017. Its last reported valuation was $346 million in Nov 2025. It has raised $97.3 million.

Last reported valuation

$346.2M

Oct 2026

Priced at

—

Total raised

$97.3M

Last round

—

How much has Highlightll Pharma raised?

$97.3Macross 0 recorded rounds

Free account

More of Highlightll Pharma with a free account

·The complete investor list: 11 names
·Watch Highlightll Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Highlightll Pharma investors

11 investors are on record for Highlightll Pharma, including CICC Capital, Hillhouse Investment Group, Shenzhen Yifeng Investment Management Enterprise and Infinity Group.

For fundraisers

Raising for a company like Highlightll Pharma?

11 investors have backed Highlightll Pharma.

See all 11 investors →

Frequently asked about Highlightll Pharma

How much has Highlightll Pharma raised?: Highlightll Pharma has raised $97.3M in total across 0 recorded funding rounds.